Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

Recruiting

Phase 2

TirzepatideEffects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

Sponsor:

University of Hawaii

Code:

NCT06935838

Conditions

Obesity and Overweight

HIV

Chronic Inflammation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-24. This information was provided to ClinicalTrials.gov by University of Hawaii on 2025-11-28.